Publications by authors named "Xiang-quan KONG"

Background: In-stent restenosis is characterized by a significant reduction in lumen diameter within the stented segment, primarily attributed to excessive proliferation of vascular smooth muscle cells (VSMCs) and neointimal hyperplasia. PFN1 (profilin-1), an actin-sequestering protein extensively studied in amyotrophic lateral sclerosis, remains less explored in neointimal hyperplasia.

Methods: Utilizing single-cell RNA sequencing alongside data from in-stent restenosis patients and various experimental in-stent restenosis models (swine, rats, and mice), we investigated the role of PFN1 in promoting VSMC phenotype switching and neointimal hyperplasia.

View Article and Find Full Text PDF
Article Synopsis
  • This study looked at how safe and effective a heart procedure called TAVI is for people with a problem called aortic regurgitation (AR).
  • 62 patients were treated using a special device called the VitaFlow over a few years, and their health was checked for 1 year after the surgery.
  • The results showed that most patients did well, with few major complications, and their heart function improved after the procedure.
View Article and Find Full Text PDF
Article Synopsis
  • * Key factors in AS development include issues like endothelial cell dysfunction, inflammation, and changes in valve cells, but there are currently no specific drugs to slow its progression.
  • * Aortic valve replacement remains the best treatment option, and the article also explores possible new therapeutic targets for managing AS.
View Article and Find Full Text PDF

Background: Drug-coated balloon (DCB) angioplasty seems a safe and effective option for specific de novo coronary lesions. However, the beneficial effect of intravascular ultrasound (IVUS)-guided DCB angioplasty in de novo lesions remains uncertain.

Objectives: This study aimed to assess the benefits of IVUS guidance over angiography guidance during DCB angioplasty in de novo coronary lesions.

View Article and Find Full Text PDF
Article Synopsis
  • Previous research suggested that transfemoral TAVR with self-expanding valves is a safe option for patients with severe aortic regurgitation (AR), but there’s a lack of randomized trial support for this treatment.
  • The SEASON-AR trial is a multi-site, randomized study involving 210 high-risk patients, comparing TAVR treatment with guideline-directed medical therapy (GDMT) to GDMT alone, focusing on key outcomes like major adverse cardiac events after 12 months.
  • This trial is the first of its kind designed to evaluate the effectiveness and safety of TAVR in high-risk patients with severe pure native AR, potentially paving the way for new treatment protocols.
View Article and Find Full Text PDF

Vascular smooth muscle cells (VSMCs), the major cell type in the arterial vessel wall, have a contractile phenotype that maintains the normal vessel structure and function under physiological conditions. In response to stress or vascular injury, contractile VSMCs can switch to a less differentiated state (synthetic phenotype) to acquire the proliferative, migratory, and synthetic capabilities for tissue reparation. Imbalances in VSMCs phenotypic switching can result in a variety of cardiovascular diseases, including atherosclerosis, in-stent restenosis, aortic aneurysms, and vascular calcification.

View Article and Find Full Text PDF

The rising prevalence of cardiovascular disease has become a global health concern. The occurrence of cardiovascular disease is the result of long-term interaction of many risk factors, one of which is diabetes. As a novel anti-diabetic drug, DPP4 inhibitor has been proven to be cardiovascular safe in five recently completed cardiovascular outcome trials.

View Article and Find Full Text PDF

Purpose: To compare the consistency of one-dimensional Response Evaluation Criteria in Solid Tumors (1D-RECIST), two-dimensional WHO criteria (2D-WHO), and three-dimensional (3D) measurement for therapeutic response assessment of nasopharyngeal carcinoma (NPC).

Materials And Methods: Retrospective data of 288 newly diagnosed NPC patients were reviewed. Tumor size was assessed on magnetic resonance imaging (MRI) according to the 1D-RECIST, 2D-WHO, and 3D measurement criteria.

View Article and Find Full Text PDF

Introduction: Provisional stenting using drug-eluting stent is effective for simple coronary bifurcation lesions. Kissing balloon inflation using conventional non-compliant balloon is the primary treatment of side branch (SB) after main vessel (MV) stenting. Drug-coating balloon (DCB) is reported to be associated with less frequent clinical events in in-stent restenosis and small vessel disease.

View Article and Find Full Text PDF

In-stent restenosis (ISR) remains an Achilles heel of drug-eluting stents despite technical advances in devices and procedural techniques. Neointimal hyperplasia (NIH) is the most important pathophysiological process of ISR. The present study mapped normal arteries and stenotic arteries to uncover potential cellular targets of neointimal hyperplasia.

View Article and Find Full Text PDF

Vascular smooth muscle cell (VSMC) phenotypic modulation plays an important role in the occurrence and development of in-stent restenosis (ISR), the underlying mechanism of which remains a key issue needing to be urgently addressed. This study is designed to investigate the role of plasma small extracellular vesicles (sEV) in VSMC phenotypic modulation. sEV were isolated from the plasma of patients with ISR (ISR-sEV) or not (Ctl-sEV) 1 year after coronary stent implantation using differential ultracentrifugation.

View Article and Find Full Text PDF

Many studies have verified the safety of combined radiotherapy and immune checkpoint blockades (ICBs) without the specific radiation dose or sequencing of combination. We aimed to evaluate the expression and response of PD-1, TIM-3, LAG-3 after neoadjuvant radiotherapy (NRT) and explore the possibility and optimal schedule of combining immunotherapy with radiotherapy in treating rectal cancer. Immunohistochemistry was performed to detect the expression of PD-1, TIM-3, LAG-3, CD8, and CD3.

View Article and Find Full Text PDF
Article Synopsis
  • Current guidelines recommend 12 months of dual antiplatelet therapy (DAPT) for acute coronary syndrome (ACS) patients after drug-eluting stent (DES) implantation, but recent studies suggest that 3 months of DAPT followed by ticagrelor alone might also be effective and safe.
  • The IVUS-ACS and ULTIMATE-DAPT trial aims to compare the safety and effectiveness of IVUS-guided versus angiography-guided DES implantation and to evaluate the impact of ticagrelor monotherapy versus ticagrelor plus aspirin on bleeding risks and major adverse cardiovascular events over a year following the procedure.
  • The study will involve 3,486 ACS patients who
View Article and Find Full Text PDF
Article Synopsis
  • This study compared target vessel failure (TVF) rates 3 years after drug-eluting stent (DES) implantation using either intravascular ultrasound (IVUS) guidance or angiographic guidance.
  • Results showed that IVUS guidance led to lower TVF rates (6.6%) compared to angiography (10.7%), primarily due to fewer clinically driven target vessel revascularizations.
  • Additionally, the incidence of stent thrombosis was also significantly lower in the IVUS group (0.1%) versus the angiography group (1.1%).
View Article and Find Full Text PDF

Background: Double kissing (DK) crush approach for patients with coronary bifurcation lesions, particularly localized at distal left main or lesions with increased complexity, is associated with significant reduction in clinical events when compared with provisional stenting. Recently, randomized clinical trial has demonstrated the net clinical benefits by intravascular ultrasound (IVUS)-guided implantation of drug-eluting stent in all-comers. However, the improvement in clinical outcome after DK crush treatment guided by IVUS over angiography guidance for patients with complex bifurcation lesions have never been studied in a randomized fashion.

View Article and Find Full Text PDF

Coronary angiography has been considered the gold standard for the diagnosis of coronary artery disease and guidance of percutaneous coronary intervention (PCI). However, 2D-projection angiography cannot completely reflect the 3D coronary lumen. Intravascular ultrasound (IVUS) can overcome a number of limitations of coronary angiography by providing more information about the dimensions of the vessel lumen, plaque characteristics, stent deployment, and the mechanisms of device failure.

View Article and Find Full Text PDF

Intravascular ultrasound (IVUS) guidance is not routinely performed in real-word clinical practice partly because the benefit of IVUS guidance is not well established. This updated meta-analysis aims to compare IVUS-guided and angiography-guided drug-eluting stent (DES) implantation, simultaneously stressing the value of an optimal IVUS-defined procedure. Medline, Scopus, Google Scholar, and Cochrane Controlled Trials Registry were searched for the randomized trials comparing IVUS-guided and angiography-guided DES implantation.

View Article and Find Full Text PDF

Aim: To assess the long-term prognostic value of vascular endothelial growth factor receptor 1 (VEGFR1) and class III β-tubulin (TUBB3) mRNA expression in non-metastatic rectal cancer.

Methods: A total of 75 consecutive patients with non-metastatic rectal cancer from March 2004 to November 2008 were analyzed retrospectively at our institute. The mRNA expressions of VEGFR1 and TUBB3 were detected by multiplex branched DNA liquid-chip technology.

View Article and Find Full Text PDF

Background: Previous studies have suggested that exogenous hydrogen sulfide can alleviate the development of diabetic cardiomyopathy (DCM) by inhibiting oxidative stress, inflammation, and apoptosis. However, the underlying mechanism is not fully understood. Nuclear expression and function of the transcription factor Forkhead box protein O (FoxO1) have been associated with cardiovascular diseases, and thus, the importance of FoxO1 in DCM has gained increasing attention.

View Article and Find Full Text PDF

Background: The relationship between platelet reactivity and long-term clinical outcomes remains controversial. The present prospective study was designed to explore the association between high platelet reactivity (HPR) on clopidogrel and long-term clinical outcomes following implantation of drug eluting stents (DES).

Methods: A total of 1769 consecutive patients assessed by Aggrestar (PL-11) were enrolled at our center from February 2011 to December 2017.

View Article and Find Full Text PDF

Present work was designed to quantitatively evaluate the performance of diffusion-weighted magnetic resonance imaging (DWI) in the diagnosis of the presence of metastasis in lymph nodes (LNs). Eligible studies were identified from systematical PubMed and EMBASE searches. Data were extracted.

View Article and Find Full Text PDF
Article Synopsis
  • * Analyzed data from 80 HCC patients with tumor thrombus over eight years, finding significant factors for overall survival (OS) include gender, radiotherapy method, biologically effective dose (BED), and performance status.
  • * Results showed that higher BED correlated with better median OS (42 months vs. 19 months for low-BED), and survival rates decreased with more advanced types of tumor thrombi, suggesting the importance of tailored palliative radiotherapy.
View Article and Find Full Text PDF

Objective: To evaluate the capacity of dual-energy computed tomography (DECT) virtual non-calcium (VNCa) images in detecting post-traumatic bone marrow lesions (BMLs) in the knee with a new grading system.

Methods: DECT and magnetic resonance (MR) imaging were used to examine acute trauma of the knee in 32 patients. VNCa images were generated by dual-energy subtraction of calcium, and the lower end of the femur and upper end of the tibia each were divided into six regions for grading of bone marrow by two musculoskeletal radiologists using a four-grading system (Grade 4, very obvious lesions; Grade 3, relatively obvious lesions; Grade 2, slight or suspicious lesion on VNCa image and mild lesion on MR image; Grade 1, normal bone marrow).

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to examine how the anti-fibrotic peptide Ac-SDKP influences vascular fibrosis by affecting ERK1/2 activity in response to Ang II.
  • - Rat vascular adventitial fibroblasts were tested in different groups to analyze collagen levels and the actions of MMP-2 and TGF-beta1 through various methods like RT-PCR and Western blot.
  • - Results indicated that Ac-SDKP reduced collagen and TGF-beta1 levels while increasing MMP-2 expression, suggesting it inhibits vascular fibrosis by interfering with the Ang II-mediated ERK1/2 pathway.
View Article and Find Full Text PDF